To investigate whether circMAPK14 affected the stability of FOXC1, we treated CRC cells with cycloheximide (CHX, an inhibitor of protein synthesis) and completed a time‐course experiment (Figures 6G and S6C–E). This evidence concerns the gene FOXC1 and colorectal carcinoma.